ALISON PELLETIER: Open Payments
NPI 1023619699 · BEVERLY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 99 payments from 13 companies in 2025. Trend: 2023 $231 · 2024 $381 · 2025 $1,799
Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $511 |
| Collegium Pharmaceutical, Inc. | 24 | $324 |
| ABBVIE INC. | 19 | $314 |
| Vanda Pharmaceuticals Inc. | 11 | $153 |
| Lundbeck LLC | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Supernus Pharmaceuticals, Inc. | 4 | $98 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| PFIZER INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: CAPLYTA, Jornay PM, VRAYLAR, REXULTI, FANAPT, Qelbree, INGREZZA, TRUMENBA.
Industry payments across MA — which companies pay providers there.
